The author is suffering from squamous cell carcinoma and is running out of treatment options.
The potential treatment that could help is mRNA tumor vaccines, which have shown significant promise for treating head and neck squamous cell carcinomas.
The FDA's slow approval process for new drugs is preventing timely access to potentially life-saving treatments, and the author calls for a stronger "right to try" presumption for terminally ill patients.
The author, who is suffering from squamous cell carcinoma, highlights the challenges of accessing potential treatments for their condition.
The FDA's cautious approach to approving treatments for diseases like squamous cell carcinoma is criticized for hindering progress and delaying access to potentially life-saving therapies.
There is a debate about the ethics and safety of allowing terminally ill patients to try experimental treatments, with calls for more flexible and faster approval processes while ensuring patient safety.
Caltech chemistry professor Rudy Marcus celebrated his 100th birthday with a symposium in his honor, showcasing his long career and contributions to science.
Marcus, a Nobel laureate in chemistry, is known for his work on electron transfer reactions and his ability to simplify complex problems.
Despite his age, Marcus continues to work and publish research papers, demonstrating his enduring curiosity and dedication to scientific exploration.
Plane is an open-source software development tool that helps manage issues, sprints, and product roadmaps in an easy and customizable way.
It offers a simple and intuitive user experience with various views like List, Kanban, and Calendar to visualize tasks and workflows.
Plane allows for easy integration with other tools, such as Slack and GitHub, and provides features like attachments, comments, and powerful notifications.